PUBLICATIONS
Publications
Schafer LN, Anders M, Makhoul I. Beyond Traditional Teaching: Feasibility of Peer-to-Peer Teaching in a Hematology-Oncology Fellowship. J Cancer Educ, September 2019, Volume 34, Issue 1, p S25.
J.S. de Bono, C. Helissey, K. Fizazi, J.P. Maroto Rey, G. Roubaud, E.S. Antonarakis, S.K. Sandhu, N.D. Shore, R. Ratta, B. Perez Valderrama, C. Vulsteke, L. Schafer, G. Marr, E. Zhao, A.F. Ward, J.M. Piulats Rodrigues, Randomized Phase II Trial of the B7-H3 Targeting Antibody Drug Conjugate (ADC) Vobramitamab Duocarmazine (vobra duo) in Metastatic Castration-Resistant Prostate Cancer (mCRPC), Annals of Oncology, Volume 35, S996 - S997, ESMO, 2024.
Botta, GP; Abdelrahim, M; Aushev, VN; Esmail, A; Drummond, B; Sharma, S; Kalashnikova, E; Hook, N; Chandana, SR; Tejani, MA; Malla, M; Schafer, LN; Kasi, PM; George, GV; Aleshin, A; Dayyani, F; Hanna, DL. Association of Personalized and Tumor-Informed ctDNA with Patient Survival Outcomes in Pancreatic Adenocarcinoma. J. Clin. Oncol., Volume 40, Issue 4, S517, ASCO GI, 2022.
Kasi, PM; Budde, G; Dayyani, F; Botta, GP; Diehl, A; King, GT; Malla, M; Abdelrahim, M; Hanna, DL; Schafer, LN; Tejani, MA; Krainock, M; Billings, PR; Olshan, P; Aushev, VN; Aleshin, A. Tumor-Informed Assessment of Circulating Tumor DNA and its Incorporation into Practice for Patients with Hepatobiliary Cancers. J. Clin. Oncol. Volume 39, Issue 15, S4103, ASCO, 2021.
Botta, GP; Abdelrahim, M; Aushev, VN; Esmail, A; Drummond, B; Sharma, S; Kalashnikova, E; Hook, N; Chandana, SR; Tejani, MA; Malla, M; Schafer, LN; Kasi, PM; George, GV; Aleshin, A; Dayyani, F; Hanna, DL. Association of Personalized and Tumor-Informed ctDNA with Patient Survival Outcomes in Pancreatic Adenocarcinoma. J. Clin. Oncol., Volume 40, Issue 4, S517, ASCO GI, 2022.
Ossama Tawfik, MD, PhD; Janakiraman Subramanian, MD; Samuel Caughron, MD; Pradip Manna, MD; Eric Ewing, MD; Matthew Aboudara, MD; John Borsa, MD; Liudmila Schafer, MD; Timothy Saettele, MD; Sreeni Jonnalagadda, MD. Challenges in Pathology Specimens Processing in the New Era of Precision Medicine. Arch Pathol Lab Med (2022) 146 (5): 603–610.
Shannon Zhang, Danielle Brazel, Priyanka Kumar, Liudmila Schafer, Benjamin Eidenschink, Maheswari Senthil, Farshid Dayyani. Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies. J Gastrointest Oncology. 2021 Dec;12(6):2643-2652.
Kasi, PM; Budde, G; Dayyani, F; Botta, GP; Diehl, A; King, GT; Malla, M; Abdelrahim, M; Hanna, DL; Schafer, LN; Tejani, MA; Krainock, M; Billings, PR; Olshan, P; Aushev, VN; Aleshin, A. Tumor-Informed Assessment of Circulating Tumor DNA and its Incorporation into Practice for Patients with Hepatobiliary Cancers. J. Clin. Oncol. Volume 39, Issue 15, S4103, ASCO, 2021.
Vuk J, McKee S, Tariq S, Mendiratta P. A Better Learning Community: Mixed-Methods Reveal Medical Student Preferences with Implications for Learning Community Design and Implementation. J Med Educ Curric Dev. 2021 May 24;8; 1-4. Acknowledged for contributions to study design and assistance in abstract writing: The authors thank Liudmila Schafer, MD; she participated in study design and aided in writing the abstract.
Joshi K, Atwal D, Siegel E,Jillella A, Konda M, Parikh R, Ananthula A, Bano K, Arnaoutakis K, Schafer L, Milojkovich N, Mahmoud F, Govindajaran R. Absolute Lymphocyte Count (ALC) as Predictor of Pneumocysstis Jiroveci Pneumonia (PCP) Infection in Patients on Immune Checkpoint Inhibitors (ICPi). American Society of Clinical Oncology (ASCO), May 2019, J Clin Oncol. e14255.
Briggler A., Sidarous G, Atwal D., Mohan M, Johnson A, Schafer L., Effect of Health Literacy Education on Chemotherapy-Induced Nausea and Vomiting. Association of VA Hematology/Oncology Annual Meeting, 2019.
Makhoul I, Motwani P, Schafer L, Arnaoutakis K, Mahmoud F, Safar M, Graves D, Mehta P, Govindarajan R, Hutchins L, Thrush C. Integrating Collaborative Learning and Competition in a Hematology/Oncology Training Program. J Cancer Educ, 2018 Feb;33(1):186-192. PMID: 27516202.
Mahmoud F, Arnaoutakis K, Motwani P, Schafer L, Mehta P, Makhoul I. Hematology/oncology fellow’s training in palliative care: results of a national survey. J Clin Oncol 33, 2015 (suppl 29S; abstr 178).
Raval M, Kumar A, Hao L, Jewell S, Sokola F, Mehta P, Arnaoutakis K, Makhoul I, Schafer L. Distress Screening at the Central Arkansas Veterans Healthcare System Hematology- Oncology Clinic: A Quality Improvement Project. Fed Pract. 2016 September 33 (sup 8):33S.
Schafer LN, Sundaram A, Sigmon J, Micklewright M, Krishnaswamy G. Subcutaneous Infusion of Immunoglobulin (SQI) May Allow Tolerance of Intravenous Immunoglobulin (IVIG) in Common Variable Immune Deficiency (CVID) With Prior Anaphylaxis. Abstracts of the Annual Meeting of the American College of Allergy, Asthma and Immunology and the 12th International Food Allergy Symposium, November 9-15, 2006, Philadelphia, Pennsylvania, USA. Ann Allergy Asthma Immunology 2007 Jan:98(Suppl 1): A3-118.
Khoruzhik SA, Rozhko VV, Schafer (Batvinkova) LN, Dovnar OS, Maslakova ND, Homback AM. CT-guided Percutaneous Biopsies: The First Experience. Proceedings of the Grodno Regional Clinical Hospital 50th Anniversary Conference; 1999; Grodno, Belarus. vol. 2, p. 233-5.
Abstracts & Presentations
National/International Meetings
Greg Botta, Diana L. Hanna, Saima Sharif, Liudmila Schafer, John Marshall, Kaushik Sen, Maen Abdelrahim, Noam Drazin, Anup Kasi, Farshid Dayyani, Michael Krainock, Griffin Budde, Vasily N. Aushev, Minu Maninder, Perry Olshan, Paul R. Billings, Alexey Aleshin. MRD detection rates with a personalized and a tumor-informed ctDNA assay in patients with stage I colorectal cancer. SAGES meeting, August 31 – September 3, 2021 in Las Vegas, NV.
Liudmila Schafer, Farshid Dayyani, Christina Wu, Megan E. McNally, Robert Amajoyi, Gregory P. Botta, Mark Lewis, Midhun Malla, Paul Fanta, Saima Sharif, Anup Kasi, Griffin Budde, Vasily Aushev, Minu Maninder, Perry Olshan, Paul R. Billings, Alexey Aleshin. Role of circulating tumor DNA for detection of molecular residual disease in patients with appendiceal tumors, post-surgery. 8th Asia Pacific Gastroenterology Cancer Summit (APGCS), August 14th-15th, 2021. Abstract Winner with a cash price.
Pashtoon Murtaza Kasi, Griffin L. Budde, Farshid Dayyani, Greg Botta, Adam Dieh, Gentry King, Midhun Malla, Maen Abdelrahim, Diana Hanna, Liudmila Schafer, Mohamedtaki Tejani, Michael Krainock, Paul R. Billings, Perry Olshan, Vasily N. Aushev, Alexey Aleshin. Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers. J Cli Oncol, Vol 39, Issue 13, Suppl., 2021.
Briggler A, Sidarous G, Atwal D, Mohan M, Johnsrud A, Schafer L. Effect of Health Literacy Education on Chemotherapy-Induced Nausea and Vomiting. Association of VA Hematology/Oncology (AVAHO) national meeting, Minneapolis, MN, September 20-22, 2019.
Joshi K, Atwal D, Siegel E,Jillella A, Konda M, Parikh R, Ananthula A, Bano K, Arnaoutakis K, Schafer L,
Milojkovich N, Mahmoud F, Govindajaran R. Absolute Lymphocyte Count (ALC) as Predictor of Pneumocysstis Jiroveci Pneumonia (PCP) Infection in Patients on Immune Checkpoint Inhibitors (ICPi). American Society of Clinical Oncology (ASCO), May 2019, J Clin Oncol. e14255.
Schafer LN, Anders M, Makhoul I. Beyond Traditional Teaching: Feasibility of Peer-to-Peer Teaching in a Hematology-Oncology Fellowship. International Cancer Education Conference (ICEC), Oral Presenter. Salt Lake City, 18 - 20 September 2019.
Schafer LN, Grodno Regional Hospital affiliated with Grodno State Medical University, Invited Speaker, “Current and Future Perspectives on Gastrointestinal Malignancies.” Grodno Regional Medical Center affiliated with Grodno State Medical University, Grodno, Republic of Belarus, Grand Round. June 29, 2017.
Schafer L, Kuc E, Raval M, Kumar A, Hao L, Sarah J, Socola F, Mehta P, Arnaoutakis K, Makhoul I, Distress Screening at the Central Arkansas Veterans Healthcare System. Hematology/Oncology Clinics: A Quality Improvement Project. 21st Conference at National Center for Quality Assessment in Health Care, Ministry of Health of Poland. Krakow, Poland, 29- 30 May 2017.
http://www.cmj.org.pl/konferencja/program.php?trm=2017-05-30.
Raval M, Kumar A, Hao L, Jewell S, Socola F, Mehta P, Arnaoutakis K, Makhoul I, Schafer L. Distress monitoring in VA Hematology/Oncology Clinics: A Quality Improvement Project. 2016 Association of VA Hematology/Oncology (AVAHO) national meeting, Dallas, TX September 2016.
Mahmoud F, Arnaoutakis K, Motwani P, Schafer L, Mehta P, Makhoul I. Hematology and Oncology Fellow’s Attitude and Knowledge in Cancer Pain Management. Palliative Care in Oncology Symposium, Boston, MA, October 9-10, 2015 J Clin Oncol 33, 2015 (suppl 29S; abstr 178). http://meetinglibrary.asco.org/record/118129/abstract.
Schafer LN, Sundaram A., Sigmon J., Krishnaswamy G., Subcutaneous Infusion of Immunoglobulin (SQI) May Allow Tolerance of Intravenous Immunoglobulin (IVIG) in Common Variable Immune Deficiency (CVID) With Prior Anaphylaxis. Annals of Allery, Asthma and Immunology 98(1): A 37, January 2007.
Local/Regional Meetings
Schafer LN Artificial Intelligence in Medicine, Georgetown University, Washington DC, August 8th, 2025.
Schafer LN Artificial Intelligence in Medicine, Georgetown University, Washington DC, December 12, 2024
Schafer LN, Biliary Tract Cancers. Rockville, MD, March 21, 2025
Schafer LN, Role Herbs and Supplements in Cancer Treatment. Gilda Club, Kansas City, MO, February 24, 2021
Schafer LN, Pancreatic cancer, UMKC, Kansas City, MO, September 30th, 2020
Schafer LN, Junior Faculty P&T Prep: Documenting Your Clinical Efforts in a Way that Counts, IDW, UAMS, Little Rock, AR, January 17, 2019
Schafer LN, Pancreatic Cancer Debate, Charles William Rasco, III Symposium on Colorectal Cancer and GI Malignancies UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, March 9, 2018
Schafer LN, Gastrointestinal Oncology, Internal Medicine Conference, UAMS, College of Medicine, Little Rock, AR, August 16, 2017
Schafer LN, Investigation of Cell Homeostasis and Tumorigenesis in Gastrointestinal Tract, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, March 29, 2017
Schafer LN, My Most Interesting Case, Charles William Rasco, III Symposium on Colorectal Cancer and GI Malignancies UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, March 3, 2017
Schafer LN, Colon Cancer Genetic Syndromes, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, Lecturer, February 16, 2017
Schafer LN, A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of
INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial
Carcinoma Harboring FGF/FGFR Alterations, Presented Protocol at Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, January 17, 2017
Schafer LN, Randomized Phase II Study of 2nd Line FOLFIRI versus Modified FOLFIRI with PARP Inhibitor ABT888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer, Disease Oriented Committee (DOC), UAMS
Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, September 28, 2016
Schafer LN, Introduction to Third Year Medical School, House “Lowe”, UAMS I. Dodd Wilson Education Building's, UAMS, August, 2016
Schafer LN, Current and Future Perspectives: Colorectal Cancer as a Prototype, Department of Internal Medicine, Grand Rounds, UAMS Fay W. Boozman College of Public Health, June 23, 2016
Schafer LN, Colorectal Cancer and Prevention, Internal Medicine Residents conference, UAMS, College of Medicine, Little Rock, May 11, 2016
Schafer LN, A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy with Radiation therapy for Patients with Unresectable or Borderline Resectable Adenocarcinoma of the Pancreas, Presenter, Gastrointestinal Disease Oriented Committee, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR,
March 30, 2016
Schafer LN, A Practical Approach to Gastrointestinal Tumors in Geriatric Population, Geriatric Grand Rounds, UAMS Donald W. Reynolds Institute on Aging, February 10, 2016
Makhoul I, Motwani P, Schafer L, Arnaoutakis K, Graves D, Mehta P. Integrating Competition and Cooperative/Collaborative Learning in a Hematology/Oncology Training Program Oral presentation. Teach the Teacher Symposium, UAMS, ED2, Little Rock AR, January 29, 2016
Schafer LN, InterAACT - An International Multicenter Open Label Randomized Phase II Advanced Anal Cancer
Trial Comparing Cisplatin plus 5-fluorouracil versus Carboplatin Plus Weekly Paclitaxel in Patients with Inoperable Locally Recurrent or Metastatic Disease, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, January 27, 2016
Schafer LN, A Prospective Observational Trial Evaluating Outcomes of Foundation One – Directed Matched Targeted Therapy in Patients with Cancer of Unknown Primary (CUP). Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, January 5, 2016
Schafer LN, A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma. Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, October 28, 2015
Schafer LN, A Randomized, Double-blind, Placebo-controlled Phase 2 Study of MM-141 plus Nab-Paclitaxel and Gemcitabine versus Nab-Paclitaxel and Gemcitabine in Front-Line Metastatic Pancreatic Cancer (CARRIE), Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, September 30, 2015
Schafer LN, Evaluation of a Microendoscopic Imaging System in Examination of Resected Tissues. Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, August 26, 2015
Schafer LN, How to Present Journal Club, Presentation to Fellows, Hematology/Oncology Fellowship Conference, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, July 3, 2015
Schafer LN, Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, June 24, 2015
Schafer LN, NCYTE 18424-363 SIV Site 027/Janus I Crossover. Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, May 12, 2015
Schafer LN, Magnetic Resonance Imaging (MRI) Restaging of Rectal Cancer Following Neoadjuvant Chemoradiation Therapy, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, May 6, 2015
Schafer LN, Pancreatic Cancer Therapy, Charles William Rasco, III Symposium on Colorectal Cancer and GI Malignancies, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, April 3, 2015
Schafer LN, Hepatobiliary Malignancies, Pancreatic Cancer, Internal Medicine Conference, UAMS, College of Medicine, ED2, Little Rock, AR, March 25, 2015
Schafer LN, An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, January 16, 2015
Schafer LN, Phase 3 Trial Compares 90Y-antibody (i.e. IP) Combined with Low-Dose, Radiosensitizing
Gemcitabine and Best Supportive Care (BSC) versus Gemcitabine and BSC, with Patients Randomized 2:1 to the Treatment Arm, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, December 29, 2014
Schafer LN, Neuropathic Pain Management, Moderator of Presentation, Hematology/Oncology Fellowship Conference, Moderator of Presentation, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR,
October 9, 2014
Schafer LN, A Phase IIb, Nonrandomized, Open-Label Trial with Mouse Renal Adenocarcinoma (RENCA) CellContaining Agarose-Agarose Macrobeads Compared with Best Supportive Care in Patients with Treatment Resistant, Metastatic Colorectal Carcinoma, Disease Oriented Committee (DOC), UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, June 18, 2014
Schafer LN, Adjuvant Treatment for Colon Cancer in the Elderly, Presenter, Charles William Rasco, III Symposium on Colorectal Cancer and GI Malignancies, UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, March 14, 2014
Schafer LN, Micro-RNA as a Potential Novel Target for the Future of Screening, Diagnosis, Treatment, and Prognosis of the Lung Cancer. UAMS Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, December 12, 2013
Schafer L, Anti-Immunoglobulin E – Monoclonal, Antibody Therapy to Treat Respiratory Disorders, Presentation at the Physician Conference at Physician Associate Clinic, Johnson City, TN, May 2006